Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2026.10.16
DATE OF BOARD MEETING
2026.09.23
POLL RESULTS OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING
2026.09.23
ag真人平台官方：深圳市ag真人平台官方药业集团股份有限公司2026年第一次临时股东会法律意见书
2026.09.23
ag真人平台官方：深圳市ag真人平台官方药业集团股份有限公司2026年第一次临时股东会决议公告
2026.09.18
2026 INTERIM REPORT
2026.09.01
NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING
2026.09.01
PROXY FORM
2026.09.01
Circulars - PROPOSED INCREASE TO THE LIMIT FOR PURCHASE OF WEALTH MANAGEMENT PRO...
2026.08.28
ag真人平台官方：关于召开2026年第一次临时股东会的通知
2026.08.28
ag真人平台官方：关于增加使用自有资金购买理财产品及进行现金管理额度的公告
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
